Wave Life Sciences announces CTA approval, initiation of Phase 1 INLIGHT
Wave Life Sciences (WVE) announced clinical trial application, CTA, approval and initiation of the Phase 1 INLIGHT clinical trial of WVE-007 in ...
Muscular Dystrophy News23 小时
Phase 2 trial shows DMD treatment ifetroban boosts heart function
Duchenne muscular dystrophy (DMD) treatment ifetroban led to improvements in measures of heart function in a Phase 2 clinical ...